CAMBRIDGE, MA -- About 60 percent of drugs on the market have hydrophobic molecules as their active ingredients. These drugs, which are not soluble in water, can be difficult to formulate into tablets ...

New and existing technologies, as well as a patient-centric focus, are pushing drug formulation into exciting directions. There are a variety of factors pushing innovation in formulation of drug ...

Artificial intelligence and machine learning can help overcome poor solubility and bioavailability. Artificial intelligence (AI) and machine learning (ML) in the biopharmaceutical industry have been ...

CDMOs are expanding to provide integrated services, enhancing outsourcing appeal. Sustainability mandates boost adoption of advanced systems, and growth is pronounced in excipient innovation and ...

As more drugs go subcutaneous, Phillips Medisize's director of Front-End Innovation, Tony Bedford, believes that high-dose ...

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized ...

Expertise in CMC (chemistry, manufacturing, and control) ensures the appropriate manufacture of a pharmaceutical or biologic by coordinating material characterization, formulation development, and ...

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...

Formatech, Inc announced the issuance of US patent 7,659,310, entitled 'Methods of Enhancing Solubility of Agents' which covers novel formulation methods to enhance the solubility of certain ...

The global oral solid dosage pharmaceutical formulation market is on a trajectory of significant expansion, projected to grow from USD 6,29,582.6 million in 2024 to USD 8,95,636.0 million by 2034.